Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-22-002327

Chief Medical Officer gave up 598 shares (to pay taxes)

  • Chief Medical Officer acquired 1,725 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Paolini John F. · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-16 Exercise or conversion : show line 1 in the form +1,725 31,725 D
2022-03-16 Shares withheld for taxes : show line 2 in the form −598 $10.13 $6,058 31,127 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-16 Exercise or conversion : show line 3 in the form Restricted Share Unit −1,725 5,175 D
Loading xslF345X03/edgar.xml…